The Kentucky SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use

Document Type : Original Article


Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA


Smokeless tobacco (SLT) prevalence was decreasing in Kentucky before 2007, but has since increased. This study examines the impact of policies on cigarette and SLT use by applying the SimSmoke tobacco control policy simulation model.
Using data from the large-scale Tobacco Use Supplement of the Current Population Survey (TUS-CPS) and information on state-specific tobacco policies, Kentucky SimSmoke is updated and extended to incorporate exclusive SLT and dual cigarette and SLT use. The model is validated using survey data through 2017. The model was used to estimate the impact on smoking and SLT prevalence and attributable deaths of policies implemented between 1993 and 2018 and the impact of stronger future policies implemented in 2018 and maintained through 2060.
SimSmoke generally reflects trends in exclusive cigarette use from the TUS-CPS and the Behavioral Risk Factor Surveillance System (BRFSS), but underestimated the increase in SLT prevalence in recent years. SimSmoke projects that policies implemented between 1993 and 2018 reduced male and female cigarette use by 23.7% and 23.0%, and male and female SLT use by 4.9% by 2018, averting 9018 tobacco-attributable deaths by 2018, increasing to 89 547 by 2060. The largest reductions in cigarette and SLT use were attributed to cigarette price increases. Strengthening tobacco control policies could reduce smoking prevalence by 41% and 40%, and reduce SLT prevalence by 33% and 25% for males and females by 2060.
Our results suggest that cigarette-oriented policies were effective in reducing SLT use but have been less successful in recent years. Future use rates can be further reduced through more restrictive statewide policies, which also target non-combustible nicotine products.


  1. Centers for Disease Control and Prevention (CDC). BRFSS Prevalence & Trends Data. CDC; 2020. Accessed July 3, 2020.
  2. Centers for Disease Control and Prevention (CDC). National Health Interview Survey. CDC; 2019.
  3. Levy DT, Tworek C, Hahn EJ, Davis RE. The Kentucky SimSmoke tobacco policy simulation model: reaching Healthy People 2010 goals through policy change. South Med J. 2008;101(5):503-507. doi:10.1097/SMJ.0b013e31816c013c
  4. American Lung Association. 'State of Tobacco Control' Report: Kentucky Gets Mostly Failing Grades for Work to Prevent Tobacco Use, Prioritize Public Health. Louisville, Kentucky: American Lung Association; 2020. Accessed July 28, 2020.
  5. Campaign for Tobacco-Free Kids. Broken Promises to Our Children: A State-by-State Look at the 1998 Tobacco Settlement 20 Years Later. Washington, DC: Campaign for Tobacco-Free Kids; 2018.
  6. Nguyen K, Marshall L, Hu S, Neff L. State-specific prevalence of current cigarette smoking and smokeless tobacco use among adults aged ≥18 years - United States, 2011-2013. MMWR Morb Mortal Wkly Rep. 2015;64(19):532-536.
  7. Nguyen KH, Marshall L, Brown S, Neff L. State-specific prevalence of current cigarette smoking and smokeless tobacco use among adults - United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(39):1045-1051. doi:10.15585/mmwr.mm6539a1
  8. Hu SS, Homa DM, Wang T, et al. State-specific patterns of cigarette smoking, smokeless tobacco use, and e-cigarette use among adults - United States, 2016. Prev Chronic Dis. 2019;16:E17. doi:10.5888/pcd16.180362
  9. High School Youth Risk Behavior Survey. Kentucky 2017 and United States 2017 Results. Centers for Disease Control and Prevention; 2017.
  10. Altria Enters Growing Oral Nicotine Products Category with on! Pouch Product. Bloomberg. June 3, 2019.
  11. Plurphanswat N, Hughes JR, Fagerström K, Rodu B. Initial information on a novel nicotine product. Am J Addict. 2020;29(4):279-286. doi:10.1111/ajad.13020
  12. Levy DT, Mumford EA, Cummings KM, et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2035-2042.
  13. Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control. 2005;16(4):347-358. doi:10.1007/s10552-004-5519-6
  14. Sinha DN, Suliankatchi RA, Gupta PC, et al. Global burden of all-cause and cause-specific mortality due to smokeless tobacco use: systematic review and meta-analysis. Tob Control. 2018;27(1):35-42. doi:10.1136/tobaccocontrol-2016-053302
  15. Levy DT, Cummings KM, Villanti AC, et al. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products. Addiction. 2017;112(1):8-17. doi:10.1111/add.13394
  16. Levy DT, Yuan Z, Li Y. The US SimSmoke tobacco control policy model of smokeless tobacco and cigarette use. BMC Public Health. 2018;18(1):696. doi:10.1186/s12889-018-5597-0
  17. Levy D, Sanchez-Romero L, Yuan Z, Li Y. The Kentucky SimSmoke Tobacco Policy Simulation Model of Cigarette and Smokeless Tobacco Use. Washington, DC: Georgetown University; 2019.
  18. State and County Intercensal Datasets: 1990-2000. United States Census Bureau; 2017. Accessed May 2019.
  19. Population projections. Accessed June 20, 2017. Published 2016.
  20. Fertility rates, mortality and birth rates by age and gender. Published 2015. Accessed August 15, 2015.
  21. United States Census Bureau. Current Population Survey, September 1993: Tobacco Use Supplement File, Technical Documentation CPS-01. Washington, DC: United States Census Bureau; 2001.
  22. Hatsukami DK, Henningfield JE, Kotlyar M. Harm reduction approaches to reducing tobacco-related mortality. Annu Rev Public Health. 2004;25:377-395. doi:10.1146/annurev.publhealth.25.102802.124406
  23. Hatsukami DK, Lemmonds C, Tomar SL. Smokeless tobacco use: harm reduction or induction approach? Prev Med. 2004;38(3):309-317. doi:10.1016/j.ypmed.2003.10.006
  24. Phillips CV, Heavner KK. Smokeless tobacco: the epidemiology and politics of harm. Biomarkers. 2009;14 Suppl 1:79-84. doi:10.1080/13547500902965476
  25. Tomar SL. Is use of smokeless tobacco a risk factor for cigarette smoking? the U.S. experience. Nicotine Tob Res. 2003;5(4):561-569. doi:10.1080/1462220031000118667
  26. Tomar SL. Epidemiologic perspectives on smokeless tobacco marketing and population harm. Am J Prev Med. 2007;33(6 Suppl):S387-397. doi:10.1016/j.amepre.2007.09.009
  27. Zhu SH, Wang JB, Hartman A, et al. Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results? Tob Control. 2009;18(2):82-87. doi:10.1136/tc.2008.028209
  28. Tam J, Day HR, Rostron BL, Apelberg BJ. A systematic review of transitions between cigarette and smokeless tobacco product use in the United States. BMC Public Health. 2015;15:258. doi:10.1186/s12889-015-1594-8
  29. Chang JT, Levy DT, Meza R. Examining the transitions between cigarette and smokeless tobacco product use in the United States using the 2002-2003 and 2010-2011 longitudinal cohorts. Nicotine Tob Res. 2018;20(11):1412-1416. doi:10.1093/ntr/ntx251
  30. Burns DM, Anderson C, Major J, Vaughn J, Shanks T. Cessation and cessation measures among daily adult smokers: National- and State-specific data.  Population Based Smoking Cessation Monograph No 12. Washington, DC: National Institutes of Health.  National Cancer Institute; 2000.
  31. McWhorter WP, Boyd GM, Mattson ME. Predictors of quitting smoking: the NHANES I followup experience. J Clin Epidemiol. 1990;43(12):1399-1405. doi:10.1016/0895-4356(90)90108-2
  32. Gilpin EA, Pierce JP, Farkas AJ. Duration of smoking abstinence and success in quitting. J Natl Cancer Inst. 1997;89(8):572-576. doi:10.1093/jnci/89.8.572
  33. United States Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989.
  34. United States Department of Health and Human Services. The Health Benefits of Smoking Cessation:  A Report of the Surgeon General. Atlanta, GA: United States Department of Health and Human Services, Public Health Service, Centers for Disease Control, Office on Smoking and Health; 1990.
  35. Schauer GL, Pederson LL, Malarcher AM. Past year quit attempts and use of cessation resources among cigarette-only smokers and cigarette smokers who use other tobacco products. Nicotine Tob Res. 2016;18(1):41-47. doi:10.1093/ntr/ntv038
  36. Messer K, Vijayaraghavan M, White MM, et al. Cigarette smoking cessation attempts among current US smokers who also use smokeless tobacco. Addict Behav. 2015;51:113-119. doi:10.1016/j.addbeh.2015.06.045
  37. Thun MJ, Myers DG, Day-Lally C, et al. Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II. In: Changes in Cigarette-Related Disease Risks and Their Implications for Prevention and Control. Bethesda, MD: National Cancer Institute; 1997:383-475.
  38. Burns D, Garfinkel L, Samet J, eds. Changes in Cigarette-Related Disease Risks and Their Implications for Prevention and Control. Bethesda, MD: National Institutes of Health, National Cancer Institute; 1997.
  39. Levy DT, Cummings KM, Hyland A. Increasing taxes as a strategy to reduce cigarette use and deaths: results of a simulation model. Prev Med. 2000;31(3):279-286. doi:10.1006/pmed.2000.0696
  40. Huang J, Gwarnicki C, Xu X, Caraballo RS, Wada R, Chaloupka FJ. A comprehensive examination of own- and cross-price elasticities of tobacco and nicotine replacement products in the U.S. Prev Med. 2018;117:107-114. doi:10.1016/j.ypmed.2018.04.024
  41. Zheng Y, Zhen C, Dench D, Nonnemaker JM. U.S. demand for tobacco products in a system framework. Health Econ. 2017;26(8):1067-1086. doi:10.1002/hec.3384
  42. Levy DT, Mays D, Boyle RG, Tam J, Chaloupka FJ. The effect of tobacco control policies on US smokeless tobacco use: a structured review. Nicotine Tob Res. 2017;20(1):3-11. doi:10.1093/ntr/ntw291
  43. Orzechowski and Walker. TThe Tax Burden on Tobacco Volume 52, 1970-2018. Arlington, VA: Orzechowski and Walker; 2018.
  44. Federal Trade Commission Smokeless Tobacco Report for 2013: Federal Trade Commission. USA; 2016. Accessed 2019.
  45. U.S. Bureau of Labor Statistics. Databases, Tables & Calculators by Subject: United States Department of Labor. Accessed 2019.
  46. Levy DT, Friend K, Polishchuk E. Effect of clean indoor air laws on smokers: the clean air module of the SimSmoke computer simulation model. Tob Control. 2001;10(4):345-351. doi:10.1136/tc.10.4.345
  47. Chronological Table of U.S. Population Protected by 100% Smokefree State or Local Laws. Accessed February 8, 2019.
  48. Huang J, Walton K, Gerzoff RB, King BA, Chaloupka FJ. State tobacco control program spending--United States, 2011. MMWR Morb Mortal Wkly Rep. 2015;64(24):673-678.
  49. Levy DT, Friend K. A computer simulation model of mass media interventions directed at tobacco use. Prev Med. 2001;32(3):284-294. doi:10.1006/pmed.2000.0808
  50. Factsheet: State Tobacco Control Expenditures, 2000-2016. Accessed September 2, 2017. Published 2017.
  51. Levy DT, Mays D, Yuan Z, Hammond D, Thrasher JF. Public health benefits from pictorial health warnings on US cigarette packs: a SimSmoke simulation. Tob Control. 2017;26(6):649-655. doi:10.1136/tobaccocontrol-2016-053087
  52. Wagener TL, Meier E, Hale JJ, et al. Pilot investigation of changes in readiness and confidence to quit smoking after E-cigarette experimentation and 1 week of use. Nicotine Tob Res. 2014;16(1):108-114. doi:10.1093/ntr/ntt138
  53. Levy DT, Graham AL, Mabry PL, Abrams DB, Orleans CT. Modeling the impact of smoking-cessation treatment policies on quit rates. Am J Prev Med. 2010;38(3 Suppl):S364-372. doi:10.1016/j.amepre.2009.11.016
  54. Quitline Stats. 2015. Accessed August 30, 2015.
  55. van Zyl-Smit RN. Electronic cigarettes: the potential risks outweigh the benefits. S Afr Med J. 2013;103(11):833.
  56. CHFS. Tobacco Use in Kentucky 2012. Frankfort, KY, US: Kentucky Department for Public Health; 2012.
  57. Levy DT, Friend K, Holder H, Carmona M. Effect of policies directed at youth access to smoking: results from the SimSmoke computer simulation model. Tob Control. 2001;10(2):108-116. doi:10.1136/tc.10.2.108
  58. Clark PI, Natanblut SL, Schmitt CL, Wolters C, Iachan R. Factors associated with tobacco sales to minors: lessons learned from the FDA compliance checks. JAMA. 2000;284(6):729-734. doi:10.1001/jama.284.6.729
  59. Choi K, Fabian LE, Brock B, Engman KH, Jansen J, Forster JL. Availability of snus and its sale to minors in a large Minnesota city. Tob Control. 2014;23(5):449-451. doi:10.1136/tobaccocontrol-2012-050719
  60. Chaloupka FJ, Tauras JA, Grossman M. Public policy and youth smokeless tobacco use. South Econ J. 1997;64:503-516.
  61. Tauras J, Powell L, Chaloupka F, Ross H. The demand for smokeless tobacco among male high school students in the United States: the impact of taxes, prices and policies. Appl Econ. 2007;39(1):31-41. doi:10.1080/00036840500427940
  62. Levy DT, Tam J, Kuo C, Fong GT, Chaloupka F. The impact of implementing tobacco control policies: the 2017 tobacco control policy scorecard. J Public Health Manag Pract. 2018;24(5):448-457. doi:10.1097/phh.0000000000000780
  63. Nelson DE, Mowery P, Tomar S, Marcus S, Giovino G, Zhao L. Trends in smokeless tobacco use among adults and adolescents in the United States. Am J Public Health. 2006;96(5):897-905. doi:10.2105/ajph.2004.061580
  64. Mumford EA, Levy DT, Gitchell JG, Blackman KO. Tobacco control policies and the concurrent use of smokeless tobacco and cigarettes among men, 1992-2002. Nicotine Tob Res. 2005;7(6):891-900. doi:10.1080/14622200500266098
  65. Agaku IT, Alpert HR. Trends in annual sales and current use of cigarettes, cigars, roll-your-own tobacco, pipes, and smokeless tobacco among US adults, 2002-2012. Tob Control. 2016;25(4):451-457. doi:10.1136/tobaccocontrol-2014-052125
  66. Bhattacharyya N. Trends in the use of smokeless tobacco in United States, 2000-2010. Laryngoscope. 2012;122(10):2175-2178. doi:10.1002/lary.23448
  67. Chang JT, Levy DT, Meza R. Trends and factors related to smokeless tobacco use in the United States. Nicotine Tob Res. 2016;18(8):1740-1748. doi:10.1093/ntr/ntw090
  68. Giovenco DP, Hammond D, Corey CG, Ambrose BK, Delnevo CD. E-cigarette market trends in traditional U.S. retail channels, 2012-2013. Nicotine Tob Res. 2015;17(10):1279-1283. doi:10.1093/ntr/ntu282
  69. U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services; 2014.
  70. Delnevo CD, Wackowski OA, Giovenco DP, Manderski MT, Hrywna M, Ling PM. Examining market trends in the United States smokeless tobacco use: 2005-2011. Tob Control. 2014;23(2):107-112. doi:10.1136/tobaccocontrol-2012-050739
  71. Economic Trends in Tobaco. Tobacco-Related Spending. CDC; 2018. Accessed May 31, 2019.
  72. Kostygina G, Ling PM. Tobacco industry use of flavourings to promote smokeless tobacco products. Tob Control. 2016;25(Suppl 2):ii40-ii49. doi:10.1136/tobaccocontrol-2016-053212
  73. Morris DS, Fiala SC. Flavoured, non-cigarette tobacco for sale in the USA: an inventory analysis of Internet retailers. Tob Control. 2015;24(1):101-102. doi:10.1136/tobaccocontrol-2013-051059
  74. National Cancer Institute (NCI), Centers for Disease Control and Prevention (CDC). Smokeless Tobacco and Public Health: A Global Perspective. Washington, DC: NCI, CDC; 2014.
  75. Mejia AB, Ling PM. Tobacco industry consumer research on smokeless tobacco users and product development. Am J Public Health. 2010;100(1):78-87. doi:10.2105/ajph.2008.152603
  76. Carpenter CM, Connolly GN, Ayo-Yusuf OA, Wayne GF. Developing smokeless tobacco products for smokers: an examination of tobacco industry documents. Tob Control. 2009;18(1):54-59. doi:10.1136/tc.2008.026583
  77. Levy DT, Yuan Z, Li Y, St Claire AW, Schillo BA. The minnesota SimSmoke tobacco control policy model of smokeless tobacco and cigarette use. Am J Prev Med. 2019;57(4):e103-e115. doi:10.1016/j.amepre.2019.06.003
  78. Lunell E, Fagerström K, Hughes J, Pendrill R. Pharmacokinetic comparison of a novel non-tobacco-based nicotine pouch (ZYN®) with conventional, tobacco-based Swedish snus and American moist snuff. Nicotine Tob Res. 2020. doi:10.1093/ntr/ntaa068
  79. Max WB, Sung HY, Lightwood J, Wang Y, Yao T. Modelling the impact of a new tobacco product: review of Philip Morris International's Population Health Impact Model as applied to the IQOS heated tobacco product. Tob Control. 2018;27(Suppl 1):s82-s86. doi:10.1136/tobaccocontrol-2018-054572
  80. McKelvey K, Baiocchi M, Halpern-Felsher B. PMI's heated tobacco products marketing claims of reduced risk and reduced exposure may entice youth to try and continue using these products. Tob Control. 2020. doi:10.1136/tobaccocontrol-2019-055318
  81. Key State-Specific Tobacco-Related Data & Ranking. Tobacco free kids website. Accessed May 31, 2019. Published 2019.
  82. Delnevo CD, Hrywna M, Foulds J, Steinberg MB. Cigar use before and after a cigarette excise tax increase in New Jersey. Addict Behav. 2004;29(9):1799-1807. doi:10.1016/j.addbeh.2004.04.024
  • Receive Date: 30 October 2019
  • Revise Date: 24 September 2020
  • Accept Date: 26 September 2020
  • First Publish Date: 27 October 2020